Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study

Completed

• Conditions: Covid19; SARS-CoV Infection; Seroprevalence

• Registration Number: NCT04839913
• Lead Sponsor: University of Cagliari

Brief Summary

The investigator analyzed the data of the patients admitted to the surgical department during the period 1St September - 10Th December 2020 to estimate the seroprevalence of SARS-CoV-2 infection in the setting of a non-dedicated COVID-19 hospital and in a mild CoV-2 incidence area and to evaluate the difference of seroprevalence between Spring and Fall seasons in a cohort of patients undergoing surgery.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-09-01
• Primary Completion: 2020-12-10
• Study Completion: 2021-01-10
• Status Verified: 2021-04
• Study First Submitted: 2021-04-07
• Study First Submitted QC: 2021-04-08
• Last Update Submitted: 2021-04-08
• Study First Posted: 2021-04-09
• Last Update Posted: 2021-04-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 121

Inclusion Criteria

• Patient admitted to our unit who had performed SARS-COV-2 serologic test

Exclusion Criteria

• age < 18

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
SARS-COV-2 seroprevalence	1St September - 10Th December 2020	SARS-COV-2 IgG and IgM seroprevalence between spring and fall period

Trial Locations

Locations (1)

University of Cagliari; 🇮🇹 Cagliari, Italy